Australia markets closed

Geron Corporation (GERN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.3300+0.0100 (+0.76%)
At close: 04:00PM EDT
1.3500 +0.02 (+1.50%)
After hours: 07:20PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.3200
Bid1.3000 x 3200
Ask1.3900 x 1200
Day's range1.2300 - 1.3800
52-week range0.9900 - 2.2300
Avg. volume2,526,646
Market cap502.005M
Beta (5Y monthly)0.98
PE ratio (TTM)N/A
EPS (TTM)-0.3590
Earnings date15 Aug 2022 - 19 Aug 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est4.00
  • Business Wire

    Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    FOSTER CITY, Calif., May 19, 2022--Geron Corporation (Nasdaq: GERN) today reported that it has granted non-statutory stock options to purchase an aggregate of 327,400 shares of Geron common stock as inducements to newly hired employees in connection with commencement of employment with the Company.

  • Zacks

    Endo (ENDP) Crashes 46.54% as it Looks to Restructure Debt

    Endo (ENDP) plunges on reports of negotiations with its lenders and senior bondholders about a possible restructuring of more than $8 billion of debt.

  • Business Wire

    Geron to Present at the H.C. Wainwright Global Investment Conference

    FOSTER CITY, Calif., May 17, 2022--Geron Corporation (Nasdaq: GERN), a late-stage biopharmaceutical company focused on the development and commercialization of treatments for hematologic malignancies, today announced that John A. Scarlett, M.D., Geron’s Chairman and Chief Executive Officer, plans to present a company overview at the H.C. Wainwright Global Investment Conference. The presentation will be available as an on-demand session beginning May 24, 2022 at 7 a.m. ET.